Axsome depression drug meets late-stage study goal, shares soar 56%
Reuters: Health
Axsome Therapeutics Inc said on Monday its drug succeeded in reducing symptoms of major depressive disorder in a late-stage trial, sending the company's share soaring 56% before the bell.
Subscribe to:
Post Comments (Atom)
Subscribe UsPopular Posts
|
The best alcohol rehab programs are meticulously specially designed to the necessities of the individual, thinking about their history, conditions and character. Fluctuating people have different issues, purposes behind their alcohol misuse and different triggers - custom fitted alcohol rehab can work with this to help you with stopping drinking. Alcoholics should basically stop drinking
ReplyDeletealcohol rehab florida